RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Tanke Biosciences - Stock

Tanke Biosciences ROA 2024

Tanke Biosciences ROA

0

Ticker

TNBI

ISIN

US87583Y1073

In 2024, Tanke Biosciences's return on assets (ROA) was 0, a 0% increase from the 0 ROA in the previous year.

Tanke Biosciences Aktienanalyse

What does Tanke Biosciences do?

Tanke Biosciences Corp is a biopharmaceutical company specializing in the development of innovative therapies for the treatment of immune system disorders. The company was founded in 2016 and is headquartered in Beijing, China. Tanke Biosciences aims to provide patients worldwide access to high-quality medicines and improve the chances of recovery for people with serious illnesses. The business model of Tanke Biosciences is based on the discovery and development of new drugs that can be used in clinics and hospitals. The company's main focus is the research of protease inhibitors, molecules that inhibit the activity of enzymes and therefore reduce inflammation. The company has acquired world-leading expertise in the development of protease inhibitors and is one of the most promising companies in the industry in this area. Tanke Biosciences has various divisions in which the company operates. One of the most important divisions is the development of drugs for the treatment of autoimmune diseases. For this purpose, the company has developed a protease inhibitor that inhibits the activity of the protein DPP4. DPP4 is involved in the regulation of the immune system and plays an important role in the development of autoimmune diseases such as diabetes or rheumatoid arthritis. The DPP4 inhibitors of Tanke Biosciences are promising candidates for improved therapy of these diseases. Another division of Tanke Biosciences is the research of cancer therapies. For this purpose, the company has developed a protease inhibitor that inhibits the activity of the enzyme Cathepsin K. Cathepsin K is involved in the development and spread of malignant tumors and thus plays an important role in the fight against cancer. The Cathepsin K inhibitors of Tanke Biosciences are promising for the development of new cancer therapies. Tanke Biosciences also offers other products and services that serve the research of molecular drugs. These include, for example, peptide libraries that researchers can use to identify new drugs. In addition, the company offers comprehensive research services to support customers in drug discovery and development. Overall, Tanke Biosciences is an innovative biopharmaceutical company specializing in the discovery and development of new drugs for the treatment of autoimmune diseases, cancer, and other immune system disorders. With its products and services, the company makes an important contribution to improving the health of people worldwide. Tanke Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Tanke Biosciences's Return on Assets (ROA)

Tanke Biosciences's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Tanke Biosciences's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Tanke Biosciences's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Tanke Biosciences’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Tanke Biosciences Stock

What is the Return on Assets (ROA) of Tanke Biosciences this year?

The Return on Assets (ROA) of Tanke Biosciences is 0 undefined this year.

What was the ROA of Tanke Biosciences compared to the previous year?

The ROA of Tanke Biosciences has increased by 0% compared to the previous year.

What consequences do high ROA have for investors of Tanke Biosciences?

A high ROA is advantageous for investors of Tanke Biosciences, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Tanke Biosciences?

A low ROA can be unfavorable for investors of Tanke Biosciences as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Tanke Biosciences affect the company?

An increase in ROA of Tanke Biosciences can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Tanke Biosciences impact the company?

A reduction in the ROA of Tanke Biosciences can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Tanke Biosciences?

Some factors that can influence the ROA of Tanke Biosciences include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Tanke Biosciences important for investors?

The ROA of Tanke Biosciences is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Tanke Biosciences take to improve ROA?

To improve ROA, Tanke Biosciences can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Tanke Biosciences pay?

Over the past 12 months, Tanke Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Tanke Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Tanke Biosciences?

The current dividend yield of Tanke Biosciences is .

When does Tanke Biosciences pay dividends?

Tanke Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Tanke Biosciences?

Tanke Biosciences paid dividends every year for the past 0 years.

What is the dividend of Tanke Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Tanke Biosciences located?

Tanke Biosciences is assigned to the '-' sector.

Wann musste ich die Aktien von Tanke Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tanke Biosciences from 6/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did Tanke Biosciences pay the last dividend?

The last dividend was paid out on 6/27/2024.

What was the dividend of Tanke Biosciences in the year 2023?

In the year 2023, Tanke Biosciences distributed 0 USD as dividends.

In which currency does Tanke Biosciences pay out the dividend?

The dividends of Tanke Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Tanke Biosciences

Our stock analysis for Tanke Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tanke Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.